La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Neuroprotective Agents (pharmacology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neuroprotective Agents (pharmacokinetics) < Neuroprotective Agents (pharmacology) < Neuroprotective Agents (therapeutic use)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000091 (2000) T. Boraud [France] ; E. Bezard ; J M Stutzmann ; B. Bioulac ; C E GrossEffects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
000094 (2000) A. Boireau [France] ; P. Dubedat ; F. Bordier ; A. Imperato ; S. MoussaouiThe protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
000217 (2001) O K Hassani [France] ; M. Mouroux ; G A Bohme ; J M Stutzmann ; J. FégerRiluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain.
000222 (2001) S. Thobois [France] ; S. Guillouet ; E. BroussolleContributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
000223 (2002) Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta ImperatoNeuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000256 (2002) Aïcha Douhou [France] ; Thomas Debeir ; Mario Gustavo Murer ; Louis Do ; Noëlle Dufour ; Véronique Blanchard ; Saliha Moussaoui ; Georg Andrees Bohme ; Yves Agid [France] ; Rita Raisman-VozariEffect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice.
000268 (2002) Anne-Marie Bonnet [France][Alpha-2 adrenergic receptors and Parkinson's disease].
000719 (2007) Laïla Amazzal [France] ; Agnès Lapôtre ; Frédéric Quignon ; Denyse BagrelMangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells.
000770 (2007) Pierre Etienne Chabrier [France] ; Michel AuguetPharmacological properties of BN82451: a novel multitargeting neuroprotective agent.
000779 (2007) Soumya Rasouri [France] ; Marie Lagouge ; Johan Auwerx[SIRT1/PGC-1: a neuroprotective axis?].
000788 (2008) Hervé Allain [France] ; Danièle Bentué-Ferrer ; Yvette AkwaDisease-modifying drugs and Parkinson's disease.
000D08 (2011) Damien Toulorge [France] ; Serge Guerreiro ; Audrey Hild ; Uwe Maskos ; Etienne C. Hirsch ; Patrick P. MichelNeuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+.
000F12 (2012) Antoine Fouillet [France] ; Clemence Levet [France] ; Angelique Virgone [France] ; Marion Robin [France] ; Pierre Dourlen [France] ; Jennifer Rieusset [France] ; Elise Belaidi [France] ; Michel Ovize [France] ; Monique Touret [France] ; Serge Nataf [France] ; Bertrand Mollereau [France]ER stress inhibits neuronal death by promoting autophagy
000F13 (2013) M. Amalric [France] ; S. Lopez ; C. Goudet ; G. Fisone ; G. Battaglia ; F. Nicoletti ; J-P Pin ; F C AcherGroup III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease.
001134 (2013) Daniel Alvarez-Fischer [France, Allemagne] ; Carmen Noelker [France, Allemagne] ; Franca Vulinovi [Allemagne] ; Anne Grünewald [Allemagne] ; Caroline Chevarin [France] ; Christine Klein [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France] ; Andreas Hartmann [France]Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model
001368 (2014) César L. Ávila ; Clarisa M. Torres-Bugeau ; Leandro R. S. Barbosa ; Elisa Morandé Sales ; Mohand O. Ouidja [France] ; Sergio B. Socías [France] ; M. Soledad Celej ; Rita Raisman-Vozari [France] ; Dulce Papy-Garcia ; Rosangela Itri ; Rosana N. ChehínStructural Characterization of Heparin-induced Glyceraldehyde-3-phosphate Dehydrogenase Protofibrils Preventing α-Synuclein Oligomeric Species Toxicity*
001406 (2014) Franziska Richter [États-Unis] ; Fuying Gao [États-Unis] ; Vera Medvedeva [États-Unis] ; Patrick Lee [États-Unis] ; Nicholas Bove [États-Unis] ; Sheila M. Fleming [États-Unis] ; Magali Michaud [France] ; Vincent Lemesre [États-Unis] ; Stefano Patassini [États-Unis] ; Krystal De La Rosa [États-Unis] ; Caitlin K. Mulligan [États-Unis] ; Pedrom Sioshansi [États-Unis] ; Chunni Zhu [États-Unis] ; Giovanni Coppola [États-Unis] ; Thierry Bordet [France] ; Rebecca Pruss [France] ; Marie-Françoise Chesselet [États-Unis]Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons
001440 (2014) Anthony H V. Schapira [Royaume-Uni] ; C Warren Olanow [États-Unis] ; J Timothy Greenamyre [États-Unis] ; Erwan Bezard [France]Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
001582 (2015) Mariza Bortolanza [Brésil] ; Roberta Cavalcanti-Kiwiatkoski [Brésil] ; Fernando E. Padovan-Neto [Brésil] ; Célia Aparecida Da-Silva [Brésil] ; Miso Mitkovski [Allemagne] ; Rita Raisman-Vozari [France] ; Elaine Del-Bel [Brésil]Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
001587 (2015) Gael Le Douaron [France] ; Fanny Schmidt [France] ; Majid Amar [France] ; Hanane Kadar [France] ; Lucila Debortoli [Brésil] ; Alexandra Latini [Brésil] ; Blandine Séon-Méniel [France] ; Laurent Ferrié [France] ; Patrick Pierre Michel [France] ; David Touboul [France] ; Alain Brunelle [France] ; Rita Raisman-Vozari [France] ; Bruno Figadère [France]Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease.
001833 (2015) Hocine Rekaik [France] ; François-Xavier Blaudin De Thé [France] ; Julia Fuchs [France] ; Olivia Massiani-Beaudoin [France] ; Alain Prochiantz [France] ; Rajiv L. Joshi [France]Engrailed Homeoprotein Protects Mesencephalic Dopaminergic Neurons from Oxidative Stress

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Neuroprotective Agents (pharmacology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Neuroprotective Agents (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Neuroprotective Agents (pharmacology)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024